Jose Luis Calapuja Chura - Academia.edu (original) (raw)
Papers by Jose Luis Calapuja Chura
Trials, 2019
Background In medical oncology settings, early specialist palliative care interventions have demo... more Background In medical oncology settings, early specialist palliative care interventions have demonstrated improvements in patient quality of life and survival compared with usual oncologic care. However, the effect of early specialist palliative care interventions in surgical oncology settings is not well studied. Methods The Surgery for Cancer with Option for Palliative Care Expert (SCOPE) Trial is a single-center, prospective, single-blind, randomized controlled trial of a specialist palliative care intervention for cancer patients undergoing non-palliative surgery. It will enroll 236 patients scheduled for major abdominal operations for malignancy, who will be randomized 1:1 at enrollment to receive usual care (control arm) or specialist palliative care consultation (intervention arm). Intervention arm patients will receive consultations from a palliative care specialist (physician or nurse practitioner) preoperatively and postoperatively. The primary outcome is physical and func...
Gynecologic Oncology, 2014
Objectives. To assess aggressive medical care, hospice utilization, and advance care documentatio... more Objectives. To assess aggressive medical care, hospice utilization, and advance care documentation among ovarian cancer patients in the final thirty days of life. Methods. Ovarian, fallopian tube, or primary peritoneal cancer patients registered at our institution during 2007-2011 were identified. Statistical analyses included Wilcoxon-Mann-Whitney, Chi-square analysis, and multivariate analysis. Results. 183 patients met inclusion criteria. Median age at diagnosis was 58. Most were white and had advanced ovarian cancer. Fifty percent had experienced at least one form of aggressive care during the last 30 days of life. Patients with provider recommendations to enroll in hospice were more likely to do so (OR 27.7, p = b 0.001), with a median hospice stay of 18 days before death. Seventy-five percent had an in-hospital DNR order and 33% had an out-of-hospital DNR order. These orders were created a median of 15 and 12 days prior to death, respectively. Twenty-eight percent had a Medical Power of Attorney and 20% had a Living Will. These documents were created a median of 381 and 378 days prior to death, respectively. Conclusions. Many ovarian cancer patients underwent some form of aggressive medical care in the last 30 days of life. The time between hospice enrollment and death was short. Patients created Medical Power of Attorney and Living Will documents far in advance of death. DNR orders were initiated close to death.
Evidencias en Odontología Clínica, 2018
El objetivo del presente trabajo fue describir la hipertrofia del músculo masetero en relación a ... more El objetivo del presente trabajo fue describir la hipertrofia del músculo masetero en relación a su etiología, características, incidencia, ayudas imagenológicas, diagnóstico, diagnóstico diferencial y alternativas de tratamiento. La hipertrofia del masetero es un trastorno de crecimiento muscular idiopático del músculo masetero que afecta no solo la simetría facial y la estética en los pacientes, sino que también afecta en algunos casos la función masticatoria. La hiperplasia del músculo masetero es una alteración benigna de crecimiento unilateral o bilateral, que afecta a la estética del paciente, está relacionado a diversas causas, predominante en la tercera década de vida, sin preferencias por el sexo masculino o femenino. El diagnóstico viene determinado por la historia clínica, el examen físico y el ultrasonido. El tratamiento puede ser de dos tipos, el tratamiento conservador y el tratamiento quirúrgico.
Trials, 2019
Background In medical oncology settings, early specialist palliative care interventions have demo... more Background In medical oncology settings, early specialist palliative care interventions have demonstrated improvements in patient quality of life and survival compared with usual oncologic care. However, the effect of early specialist palliative care interventions in surgical oncology settings is not well studied. Methods The Surgery for Cancer with Option for Palliative Care Expert (SCOPE) Trial is a single-center, prospective, single-blind, randomized controlled trial of a specialist palliative care intervention for cancer patients undergoing non-palliative surgery. It will enroll 236 patients scheduled for major abdominal operations for malignancy, who will be randomized 1:1 at enrollment to receive usual care (control arm) or specialist palliative care consultation (intervention arm). Intervention arm patients will receive consultations from a palliative care specialist (physician or nurse practitioner) preoperatively and postoperatively. The primary outcome is physical and func...
Gynecologic Oncology, 2014
Objectives. To assess aggressive medical care, hospice utilization, and advance care documentatio... more Objectives. To assess aggressive medical care, hospice utilization, and advance care documentation among ovarian cancer patients in the final thirty days of life. Methods. Ovarian, fallopian tube, or primary peritoneal cancer patients registered at our institution during 2007-2011 were identified. Statistical analyses included Wilcoxon-Mann-Whitney, Chi-square analysis, and multivariate analysis. Results. 183 patients met inclusion criteria. Median age at diagnosis was 58. Most were white and had advanced ovarian cancer. Fifty percent had experienced at least one form of aggressive care during the last 30 days of life. Patients with provider recommendations to enroll in hospice were more likely to do so (OR 27.7, p = b 0.001), with a median hospice stay of 18 days before death. Seventy-five percent had an in-hospital DNR order and 33% had an out-of-hospital DNR order. These orders were created a median of 15 and 12 days prior to death, respectively. Twenty-eight percent had a Medical Power of Attorney and 20% had a Living Will. These documents were created a median of 381 and 378 days prior to death, respectively. Conclusions. Many ovarian cancer patients underwent some form of aggressive medical care in the last 30 days of life. The time between hospice enrollment and death was short. Patients created Medical Power of Attorney and Living Will documents far in advance of death. DNR orders were initiated close to death.
Evidencias en Odontología Clínica, 2018
El objetivo del presente trabajo fue describir la hipertrofia del músculo masetero en relación a ... more El objetivo del presente trabajo fue describir la hipertrofia del músculo masetero en relación a su etiología, características, incidencia, ayudas imagenológicas, diagnóstico, diagnóstico diferencial y alternativas de tratamiento. La hipertrofia del masetero es un trastorno de crecimiento muscular idiopático del músculo masetero que afecta no solo la simetría facial y la estética en los pacientes, sino que también afecta en algunos casos la función masticatoria. La hiperplasia del músculo masetero es una alteración benigna de crecimiento unilateral o bilateral, que afecta a la estética del paciente, está relacionado a diversas causas, predominante en la tercera década de vida, sin preferencias por el sexo masculino o femenino. El diagnóstico viene determinado por la historia clínica, el examen físico y el ultrasonido. El tratamiento puede ser de dos tipos, el tratamiento conservador y el tratamiento quirúrgico.